Anthill Ventures in pact with HCG to launch health tech accelerator

Our Bureau Hyderabad | Updated on September 18, 2018

Anthill Ventures, an investment firm, has joined hands with HealthCare Global Enterprises (HCG), a cancer care provider in the country, to launch Lumos — a market-access programme for health tech start-ups.

The 12-month programme, exclusively designed for health tech start-ups, will cover areas such as oncology, fertility, precision medicine, genomics, research and diagnostics. Besides getting access to new customers with the help of the two partners, the start-ups can get funding of up to $1 million.

“They will get access to high end environment for faster product development and a platform to showcase their products to the target audience,” Bharani Setlur, Partner at Anthill Ventures and Program Director of Lumos, said. “With this new partnership, we are expanding our focus on the health tech vertical,” he said.

“Lumos will lead to disruption in multiple areas, including novel treatment ideas, enhanced patient experience as well as efficiency of healthcare operations to name a few,” said BS Ajaikumar, Chairman and Chief Executive Officer, HCG. The last date for submitting applications is October 15.

Published on September 18, 2018

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor